Markel Group Inc. Has $14.69 Million Stock Position in CME Group Inc. $CME

Posted by Renee Jackson on Jul 12th, 2026

Markel Group Inc. grew its position in CME Group Inc. (NASDAQ:CME – Free Report) by 8.7% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 49,750 shares of the financial services provider’s stock after acquiring an additional 4,000 shares during the quarter. Markel Group Inc.’s holdings in CME Group were worth $14,694,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Sachetta LLC lifted its position in CME Group by 637.1% in the first quarter. Sachetta LLC now owns 774 shares of the financial services provider’s stock worth $229,000 after purchasing an additional 669 shares during the period. WealthShield Partners LLC increased its holdings in CME Group by 0.6% in the 1st quarter. WealthShield Partners LLC now owns 11,832 shares of the financial services provider’s stock valued at $3,494,000 after buying an additional 71 shares during the period. Simplicity Wealth LLC raised its stake in shares of CME Group by 31.9% in the 1st quarter. Simplicity Wealth LLC now owns 2,413 shares of the financial services provider’s stock valued at $713,000 after buying an additional 584 shares in the last quarter. Sequoia Financial Advisors LLC lifted its holdings in shares of CME Group by 3.6% during the 1st quarter. Sequoia Financial Advisors LLC now owns 27,139 shares of the financial services provider’s stock worth $8,016,000 after acquiring an additional 950 shares during the period. Finally, Whipplewood Advisors LLC lifted its holdings in shares of CME Group by 2,075.0% during the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 83 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Price Performance

CME Group stock traded up $0.56 during trading hours on Friday, hitting $240.27. 1,979,543 shares of the stock were exchanged, compared to its average volume of 3,891,472. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market capitalization of $87.06 billion, a P/E ratio of 20.50, a P/E/G ratio of 2.69 and a beta of 0.25. CME Group Inc. has a 12 month low of $218.31 and a 12 month high of $329.16. The business’s 50-day moving average is $262.66 and its two-hundred day moving average is $283.19.

CME Group (NASDAQ:CME – Get Free Report) last posted its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The company had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.77 billion. During the same quarter in the previous year, the company posted $2.80 earnings per share. CME Group’s quarterly revenue was up 14.5% compared to the same quarter last year. Equities research analysts expect that CME Group Inc. will post 12.24 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th were issued a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a dividend yield of 2.2%. The ex-dividend date was Tuesday, June 9th. CME Group’s dividend payout ratio is presently 44.37%.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

Positive Sentiment: CME announced new products aimed at expanding trading activity, including Treasury LINK for U.S. Treasury spread trading and a new agriculture index that offers a unified benchmark for the global farm economy. CME Group to launch Treasury LINK for enhanced US Treasury spread trading CME Group’s New Agriculture Index Delivers Unified Price Benchmark for the Global Farm Economy
Neutral Sentiment: Morgan Stanley kept an overweight rating but lowered its price target on CME to $324 from $353, while Barclays cut its target to $270 and moved to equal weight, signaling reduced near-term expectations but not a fundamentally bearish view. Morgan Stanley cuts CME price target Barclays cuts CME price target
Negative Sentiment: The CFTC blocked CME’s plan to fast-track 24/7 crude oil futures trading, a setback that could limit a potentially important new revenue stream and raises regulatory risk around product innovation. CFTC to block CME’s plan for 24/7 crude oil futures trading CFTC Blocks for Now CME’s Plan to Offer 24/7 Oil Futures
Negative Sentiment: Reports also pointed to weaker trading volumes and rising competition weighing on CME Group, which could pressure transaction-based revenue growth if activity remains soft. Competition And Weaker Trading Volumes Are Weighing On CME Group (CME) Stock

Insider Activity at CME Group

In other CME Group news, insider Hilda Harris Piell sold 5,753 shares of the stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the sale, the insider owned 27,702 shares of the company’s stock, valued at $8,438,860.26. This represents a 17.20% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director William R. Shepard acquired 325 shares of the stock in a transaction on Thursday, June 25th. The stock was bought at an average price of $230.57 per share, with a total value of $74,935.25. Following the transaction, the director directly owned 260,442 shares in the company, valued at approximately $60,050,111.94. This represents a 0.12% increase in their position. The SEC filing for this purchase provides additional information. 0.30% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of research firms recently weighed in on CME. Morgan Stanley lowered their target price on shares of CME Group from $353.00 to $324.00 and set an “overweight” rating on the stock in a research note on Friday. Wall Street Zen downgraded CME Group from a “hold” rating to a “sell” rating in a report on Sunday. Keefe, Bruyette & Woods upgraded CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price objective on the stock in a research note on Thursday, June 18th. JPMorgan Chase & Co. increased their target price on CME Group from $266.00 to $271.00 and gave the stock an “underweight” rating in a report on Thursday, April 16th. Finally, UBS Group cut their target price on CME Group from $310.00 to $260.00 and set a “buy” rating for the company in a research report on Monday, July 6th. Twelve equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, CME Group currently has an average rating of “Moderate Buy” and an average price target of $293.59.

Read Our Latest Analysis on CME Group

About CME Group

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.